AmerisourceBergen Corporation (ABC): Price and Financial Metrics
AmerisourceBergen Corporation (ABC)
Today's Latest Price: $97.99 USD
Updated Oct 20 6:30pm
Add ABC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 70 in Medical - Services
See all "A" rated Strong Buy stocks
ABC Stock Summary
- Amerisourcebergen Corp's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 99.37% of US listed stocks.
- With a price/sales ratio of 0.11, Amerisourcebergen Corp has a higher such ratio than only 3.25% of stocks in our set.
- In terms of volatility of its share price, ABC is more volatile than only 2.19% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to Amerisourcebergen Corp, a group of peers worth examining would be DXLG, SYY, MCK, MAT, and BGI.
- Visit ABC's SEC page to see the company's official filings. To visit the company's web site, go to www.amerisourcebergen.com.
ABC Stock Price Chart Interactive Chart >
ABC Price/Volume Stats
| Current price | $97.99 | 52-week high | $106.45 |
| Prev. close | $97.80 | 52-week low | $72.06 |
| Day low | $97.39 | Volume | 726,091 |
| Day high | $99.00 | Avg. volume | 1,358,037 |
| 50-day MA | $97.55 | Dividend yield | 1.72% |
| 200-day MA | $93.67 | Market Cap | 20.00B |
AmerisourceBergen Corporation (ABC) Company Bio
AmerisourceBergen Corporation sources and distributes pharmaceutical products to healthcare providers, pharmaceutical and biotech manufacturers, and specialty drug patients in the United States and internationally. The company was founded in 1985 and is based in Chesterbrook, Pennsylvania.
ABC Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $97.99 | $22.93 | -77% |
Below please find a table outlining a discounted cash flow forecast for ABC, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Amerisourcebergen Corp ranked in the 18th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. The most interesting components of our discounted cash flow analysis for Amerisourcebergen Corp ended up being:
- Amerisourcebergen Corp's weighted average cost of capital (WACC) is 8%; for context, that number is higher than merely 23.8% of tickers in our DCF set.
- ABC's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than merely 23.8% of tickers in our DCF set.
- As a business, Amerisourcebergen Corp experienced a tax rate of about 0% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than only 0% of stocks generating free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -77% |
| 1% | -77% |
| 2% | -77% |
| 3% | -76% |
| 4% | -76% |
| 5% | -76% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as ABC, try DHR, ICUI, TFX, EHC, and MMSI.
Loading social stream, please wait...